I agree that this site is using cookies. You can find further informations here.
X
Dabbous, O.
150  results:
Search for persons X
?
1

EE10 The Impact of Spinal Muscular Atrophy Type 1 (SMA1) on..:

Patel, A ; Toro, W ; Martins, de Lana J..
Value in Health.  27 (2024)  6 - p. S58 , 2024
Link: https://doi.org/10.1016/..
 
?
2

P02 Real-world data for patients with gestational age ≤35 w..:

Finkel, R. ; Dabbous, O. ; Benguerba, K....
Neuromuscular Disorders.  33 (2023)  - p. S162 , 2023
Link: https://doi.org/10.1016/..
 
?
3

HSD65 From the Triple Aim to the Quintuple Aim to the ISPOR..:

Garrison, L. ; Yen, M. ; Salimullah, T...
Value in Health.  26 (2023)  6 - p. S249 , 2023
Link: https://doi.org/10.1016/..
 
?
4

RWD164 The Impact of Spinal Muscular Atrophy (SMA) Type 1 o..:

Patel, A. ; Yang, K. ; Toro, W...
Value in Health.  26 (2023)  12 - p. S536 , 2023
Link: https://doi.org/10.1016/..
 
?
5

P79 Real-world outcomes of disease-modifying treatment for ..:

Dabbous, O. ; LaMarca, N. ; Toro, W....
Neuromuscular Disorders.  33 (2023)  - p. S136 , 2023
Link: https://doi.org/10.1016/..
 
?
6

P231 Early intervention and speed-to-effect in spinal muscu..:

Toro, W. ; Reyna, S. ; Ritter, S....
Neuromuscular Disorders.  33 (2023)  - p. S93 , 2023
Link: https://doi.org/10.1016/..
 
?
7

HSD88 A Practical Approach for the Adoption of the Hub and ..:

Saleh, S. ; Dabbous, O. ; Sullivan, S....
Value in Health.  26 (2023)  6 - p. S253 , 2023
Link: https://doi.org/10.1016/..
 
?
8

CO41 Real-World Outcomes of Nusinersen or Onasemnogene Abep..:

Dabbous, O. ; Yang, M. ; Georgieva, M....
Value in Health.  26 (2023)  6 - p. S21-S22 , 2023
Link: https://doi.org/10.1016/..
 
?
9

PT42 The Impact of Spinal Muscular Atrophy Type 2 on Caregi..:

Patel, A. ; Toro, W. ; Esquerro, M.E..
Value in Health.  26 (2023)  12 - p. S540 , 2023
Link: https://doi.org/10.1016/..
 
?
10

CO177 The Burden of Spinal Muscular Atrophy Type 1 on Careg..:

Patel, A. ; Toro, W. ; Motrunich, A....
Value in Health.  26 (2023)  6 - p. S48 , 2023
Link: https://doi.org/10.1016/..
 
?
11

PCR61 The Burden of Spinal Muscular Atrophy Type 2 (SMA2) o..:

Toro, W ; Tanaka, S ; Patel, A...
Value in Health.  25 (2022)  12 - p. S401 , 2022
Link: https://doi.org/10.1016/..
 
?
12

PCR262 Real-World Outcomes and Health Care Resource Utiliza..:

Dabbous, O ; Yang, M ; Georgieva, M...
Value in Health.  25 (2022)  12 - p. S441 , 2022
Link: https://doi.org/10.1016/..
 
?
13

POSC158 The Burden of Spinal Muscular Atrophy Type 1 (SMA1)..:

Toro, W ; Tanaka, S ; Patel, A...
Value in Health.  25 (2022)  1 - p. S118 , 2022
Link: https://doi.org/10.1016/..
 
?
14

EE462 Value-Based Pricing for Patent-Protected Medicines: P..:

Garrison, LP ; Jiao, B ; Dabbous, O
Value in Health.  25 (2022)  7 - p. S425 , 2022
Link: https://doi.org/10.1016/..
 
?
15

SMA – OUTCOME MEASURES AND REGISTRIES:

Dabbous, O. ; Yang, M. ; Georgieva, M....
Neuromuscular Disorders.  31 (2021)  - p. S128 , 2021
Link: https://doi.org/10.1016/..
 
1-15